82 related articles for article (PubMed ID: 2080842)
1. Pharmacokinetic and residue studies of quinolone compounds and olaquindox in poultry.
Anadón A; Martinez-Larrañaga MR; Diaz MJ; Velez C; Bringas P
Ann Rech Vet; 1990; 21 Suppl 1():137S-144S. PubMed ID: 2080842
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to the quinolones and fluoroquinolones for the development of generic and specific immunoassays for detection of these residues in animal products.
Bucknall S; Silverlight J; Coldham N; Thorne L; Jackman R
Food Addit Contam; 2003 Mar; 20(3):221-8. PubMed ID: 12623645
[TBL] [Abstract][Full Text] [Related]
3. [Quinolones: historic review].
Rothlin RP
Medicina (B Aires); 1999; 59 Suppl 1():3-7. PubMed ID: 10436548
[TBL] [Abstract][Full Text] [Related]
4. Enrofloxacin: a new antimicrobial agent.
Schroder J
J S Afr Vet Assoc; 1989 Jun; 60(2):122-4. PubMed ID: 2691696
[TBL] [Abstract][Full Text] [Related]
5. Novel fluoroquinolone antibacterial agents containing oxime-substituted (aminomethyl)pyrrolidines: synthesis and antibacterial activity of 7-(4-(aminomethyl)-3-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6- fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid (LB20304).
Hong CY; Kim YK; Chang JH; Kim SH; Choi H; Nam DH; Kim YZ; Kwak JH
J Med Chem; 1997 Oct; 40(22):3584-93. PubMed ID: 9357525
[TBL] [Abstract][Full Text] [Related]
6. [In vitro evaluation of lomefloxacin].
Dette GA; Knothe H
Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
[TBL] [Abstract][Full Text] [Related]
7. Research on antibacterial and antifungal agents. III. Synthesis of 1-ethyl-1,4-dihydro-4-oxo-7-(1-pyrryl)quinoline-3-carboxylic acid and of some 6-derivatives.
Artico M; Corelli F; Massa S; Stefancich G; Panico S; Simonetti N
Farmaco Sci; 1984 Nov; 39(11):910-24. PubMed ID: 6440810
[TBL] [Abstract][Full Text] [Related]
8. Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, a new antimicrobial agent, and the related pyridonecarboxylic acids.
Okezaki E; Terasaki T; Nakamura M; Nagata O; Kato H; Tsuji A
Drug Metab Dispos; 1988; 16(6):865-74. PubMed ID: 2907467
[TBL] [Abstract][Full Text] [Related]
9. Assessment of biological half life using in silico QSPkR approach: a self organizing molecular field analysis (SOMFA) on a series of antimicrobial quinolone drugs.
Goel H; Sinha VR; Thareja S; Aggarwal S; Kumar M
Int J Pharm; 2011 Aug; 415(1-2):158-63. PubMed ID: 21664443
[TBL] [Abstract][Full Text] [Related]
10. New classification and update on the quinolone antibiotics.
King DE; Malone R; Lilley SH
Am Fam Physician; 2000 May; 61(9):2741-8. PubMed ID: 10821154
[TBL] [Abstract][Full Text] [Related]
11. Residue depletion and tissue-plasma correlation of methyl-3-quinoxaline-2-carboxylic acid after dietary administration of olaquindox in pigs.
Yang B; Huang L; Wang Y; Liu Y; Tao Y; Chen D; Liu Z; Fang K; Chen Y; Yuan Z
J Agric Food Chem; 2010 Jan; 58(2):937-42. PubMed ID: 20039635
[TBL] [Abstract][Full Text] [Related]
12. Quinolone antimicrobial agents: structure-activity relationships.
Zhang MQ; Haemers A
Pharmazie; 1991 Oct; 46(10):687-700. PubMed ID: 1803382
[TBL] [Abstract][Full Text] [Related]
13. Cross resistance of quinolone derivatives in gram-negative bacteria.
Barba D; Pennucci C; Esposito S; Galante D
Chemioterapia; 1985 Apr; 4(2):192-6. PubMed ID: 3159488
[TBL] [Abstract][Full Text] [Related]
14. Research on antibacterial and antifungal agents. XI. New antibacterial quinolones related to pirfloxacin.
Massa S; Corelli F; Mai A; Artico M; Panico S; Simonetti N
Farmaco; 1989 Sep; 44(9):779-93. PubMed ID: 2604833
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure, and antibacterial activity of 4-imino-1, 4-dihydrocinnoline-3-carboxylic acid and 4-oxo-1, 4-dihydrocinnoline-3-carboxylic acid derivatives as isosteric analogues of quinolones.
Stańczak A; Ochocki Z; Martynowski D; Główka M; Nawrot E
Arch Pharm (Weinheim); 2003 Mar; 336(1):18-30. PubMed ID: 12666250
[TBL] [Abstract][Full Text] [Related]
16. Reservoir of quinolone residues in fish.
Steffenak I; Hormazabal V; Yndestad M
Food Addit Contam; 1991; 8(6):777-80. PubMed ID: 1667390
[TBL] [Abstract][Full Text] [Related]
17. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
[TBL] [Abstract][Full Text] [Related]
18. Researches on antibacterial and antifungal agents. II - Synthesis of 1-ethyl-1,4-dihydro-4-oxo-7-(1-pyrrolidinyl)quinoline-3-carboxylic acid, a novel highly active, broad-spectrum antibacterial agent related to piromidic acid.
Corelli F; Massa S; Stefancich G; Artico M; Panico S; Simonetti N
Farmaco Sci; 1984 Feb; 39(2):95-109. PubMed ID: 6425079
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and residues of enrofloxacin in chickens.
Anadón A; Martínez-Larrañaga MR; Díaz MJ; Bringas P; Martínez MA; Fernàndez-Cruz ML; Fernández MC; Fernández R
Am J Vet Res; 1995 Apr; 56(4):501-6. PubMed ID: 7785830
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
